Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Pechala's Reports
$10.00
Provider: Pechala's Reports
$15.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Incumaker Inc Completes Acquisition Of Cryogenic Therapy Company


Monday, 9 Sep 2013 12:42pm EDT 

Incumaker Inc announced that it had completed the acquisition of CryoMist I, LLC and CryoMist II, LLC (collectively, CryoMist) with a third acquisition of CryoMist III, LLC planned to close by early 2014. CryoMist is on the forefront of Cryogenic Therapy which is the general use of low temperatures in medical therapy. CryoMist stimulates the body's natural healing abilities with extreme cold to induce responses on three levels: the Circulatory System, the Energy Meridians and the Nervous System. 

Company Quote

0.04
0.0 -2.44%
23 Jul 2014